Pathogenic mycobacteria induce the formation of complex cellular aggregates called granulomas that are the hallmark of tuberculosis 1,2 . Here we examine the development and consequences of vascularisation of the tuberculous granuloma in the zebrafish-Mycobacterium marinum infection model characterised by organised granulomas with necrotic cores that bear striking resemblance to those of human tuberculosis 2 . Using intravital microscopy in the transparent larval zebrafish, we show that granuloma formation is intimately associated with angiogenesis. The initiation of angiogenesis in turn coincides with the generation of local hypoxia and transcriptional induction of the canonical pro-angiogenic molecule VEGFA. Pharmacological inhibition of the VEGF pathway suppresses granuloma-associated angiogenesis, reduces infection burden and limits dissemination. Moreover, anti-angiogenic therapies synergise with the first-line anti-tubercular antibiotic rifampicin as well as with the antibiotic metronidazole, which targets hypoxic bacterial populations 3 . Our data suggest that mycobacteria induce granuloma-associated angiogenesis, which promotes mycobacterial growth and increases spread of infection to new tissue sites. We propose the use of anti-angiogenic agents, now being used in cancer regimens, as a host-targeting TB therapy, particularly in extensively drug-resistant disease where current antibiotic regimens are largely ineffective.
In its natural ectothermic hosts, Mycobacterium marinum, the closest relative of the M. tuberculosis complex, causes a disease called fish tuberculosis, a systemic wasting disease with organised epithelioid granulomas with necrotic cores. In zebrafish larvae, mycobacterium-infected macrophages form early granulomas, undergo a hallmark epithelioid transformation, and activate granuloma-specific gene expression programs 2, 9 .
To monitor host vasculature in zebrafish, we used the Tg(kdrl:egfp) s843 line (referred to hereafter as Tg(flk1:EGFP)), in which vascular endothelial cells are fluorescently labelled 10 . Injection of mycobacteria into the most commonly used caudal vein (CV) site results in granulomas in the immediate vicinity of the richly-vascularised area of the caudal haematopoietic tissue (CHT) ( Figure 1A ). To determine if a different injection site with sparser and smaller blood vessels was more suitable to detect angiogenesis, assessed primary granulomas that typically formed dorsally after injection into the trunk ( Figure 1B and 1C) . As with CV injection, trunk injection resulted in most bacteria becoming macrophageresident in granulomas (Extended Data 1A). Trunk granulomas progressed similarly to CV granulomas, with dissemination into richly-vascularised areas 11 (Supplementary Video 1). Using Tg(mpeg1:tomato-caax xt3 ) larvae, where macrophages are labelled by membranebound Tomato, revealed similar macrophage dynamics 11 , including the interstitial egress of infected macrophages, the transfer of M. marinum between granulomas, and coalescence of distal bacteria into existing granulomas (Supplementary Videos 2-4). Some infected macrophages invaded vasculature around the primary granuloma (Extended Data 1B and Supplementary Video 5).
Imaging of trunk-infected larvae revealed angiogenesis, with growth of vasculature around sites of infection. We observed sprouting from the existing intersegmental vessels (ISVs) starting at 4 dpi, just after the formation of granulomas ( Figure 1C ). We assessed the features of vessel sprouting through long-term live imaging of infected larvae (Supplementary Videos 6-9). Vessel growth occurred in spurts with extended periods of quiescence or even reversed directionality (Extended Data 1C).
To examine the mode of vascular elongation, we used blue-fluorescent M. marinum to infect the transgenic zebrafish line Tg(fli1a:nlsEGFP y7 ; flk1:mCherryi s5 ), in which endothelial nuclei are marked by EGFP expression. At 4 dpi, nuclei left the highly-organised ISVs, always towards sites of infection, and subsequently divided within the somites (Extended Data 1D and Supplementary Video 10). Vessels sprouted from both arterial and venous ISVs (Extended Data 1E).
We determined whether new blood vessels generated around the granuloma were functional. Using DsRed-labelled erythrocytes in the transgenic line Tg(flk1:EGFP; gata1:DsRed sd2 ) we found substantial blood flow through both ectopic vessels that spanned existing vessels completely and into newer blind-ending vessels (Extended Data 1F).
Angiogenesis required persistent M. marinum infection; it did not develop following injection of PBS, heat-killed M. marinum or non-pathogenic Escherichia coli (Extended Data 2A). Tumour-associated macrophages are important drivers of tumour angiogenesis upon tumour hypoxia 12 . Since macrophages serve as a principal repository of virulent mycobacteria, we assessed if there were differences in vascular recruitment between macrophage-resident and extracellular mycobacteria. Infection of double transgenic Tg(flk1:EGFP, mpeg1:tomato-caax xt3 ) embryos infected with M. marinum-cerulean allowed us to discriminate between intracellular and extracellular bacteria (Figure 2A) To demonstrate a functional requirement for macrophages in recruiting vasculature we performed morpholino knockdown of the transcription factor Pu.1/Spi1, which fully ablates all macrophages through 5 dpf 13 (Extended Data 2C). As previously reported 14 , infection burden was markedly increased in the Spi1 knockdown animals (Extended Data 2D). Despite increased burden, the total length of abnormal vasculature was decreased in morpholino-injected animals compared with controls, suggesting that macrophages specifically mediate new vessel growth in the context of inflammation ( Figure 2B ).
Vascularisation coincided with the formation of granulomas at around 4 dpi. We disrupted mycobacterium-driven granuloma formation, using an ESX1-deficient M. marinum strain (ΔESX1) deficient for granuloma formation 15 . We infected with 7.5-fold excess ΔESX1 over wildtype, to generate equivalent bacterial burdens at 4 dpi (Extended Data 2E). As expected, both strains were predominantly macrophage-resident, but ΔESX1 infection resulted in fewer granulomas and a marked reduction in angiogenesis ( Figure 2C ). Thus, macrophage residence per se is not sufficient to induce angiogenesis. Rather, macrophages that have undergone further differentiation to form granulomas appear to be required.
When we analysed the relationship between the size of individual infection foci and the length of recruited vasculature we found a strong correlation (Extended Data 3A). This relationship is reminiscent of the angiogenic switch, in which tumour size is directly related to the requirement for vascularisation due to the development of local hypoxia 5 .
We therefore asked whether hypoxia develops within granulomas. Activation of HIF-1α increases transcription of prolyl hydroxylase 3 (phd3), which serves as a reporter for hypoxic conditions in zebrafish larvae 16, 17 . We detected robust expression of phd3 within trunk granulomas, but not CHT granulomas, which are already proximate to vasculature (Extended Data 3B) consistent with a lack of hypoxia in the CHT 18 . Conversely, to assess whether mycobacteria within granulomas were experiencing hypoxia, we investigated the effect of metronidazole treatment 19 . Metronidazole specifically kills anaerobically-growing bacteria including anaerobically-growing M. tuberculosis, but is ineffective during aerobic growth 3, 19, 20 . We utilised a nitroreductase-expressing transgenic line Tg(lyzC:ntr-p2A-lanYFP xt14 ) to titrate a biologically active dose of metronidazole (Extended Data 3C). Consistent with the phd3 staining, metronidazole treatment reduced bacterial burden in trunk-infected animals but not CV-infected larvae ( Figure 2D ).
In tumours, hypoxia is known to induce VEGF expression, which in turn stimulates angiogenesis 21 . VEGF has been associated with TB pathogenesis: it is induced in active pulmonary TB 22 , and, in a rat corneal model, mediates neovascularisation in granulomas triggered by mycobacterial trehalose-6,6′-dimycolate 23 . VEGF plays a conserved role in homeostatic blood vessel recruitment in zebrafish 24 . We observed strong vegfaa expression around sites of mycobacterial granulomas in the trunk ( Figure 2E ). Similar expression levels were also observed around CHT granulomas indicating that initiation of pro-angiogenic signalling is not dependent on prior development of hypoxia during infection (Extended Data 4A). Analysis of stained sections revealed cells around the edge of mycobacterial granulomas expressing vegfaa, an observation consistent with a primarily macrophagedriven expression pattern that could be reduced by macrophage depletion (Extended Data 4B). In addition to its role in angiogenesis, VEGFA plays an important role in driving vascular permeability 25 . We performed microangiography on infected animals and found increased vascular leakage, suggesting a local effect of vegfaa expression around infection foci (Extended Data 4C).
Angiogenesis and, specifically, VEGFR signalling have been targeted in cancer therapies. Our findings suggested that these therapies might also be useful for mycobacterial infections. We chose the well-characterised small molecule SU5416, a prototypical tyrosine kinase receptor, and pazopanib, a clinically relevant VEGFR inhibitor 26, 27 . Treatment of infected animals with SU5416 or pazopanib prevented ectopic angiogenesis around the forming granulomas in Tg(flk1:EGFP) animals and reduced net bacterial burdens ( Figure  3A and Extended Data 5A). Neither compound affected in vitro growth of M. marinum, suggesting that the effect on bacterial burden was through targeting host pathways (Extended Data 5B). We confirmed that the treatments were specifically targeting angiogenesis since bacterial burdens were lowered only in trunk-infected and not in CVinfected animals (Extended Data 5C). Additionally, in trunk-infected animals, growth restriction did not occur until after the initiation of angiogenesis at 4 dpi (Extended Data 5D). To determine if VEGFR inhibition affected macrophage recruitment, we compared the association of bacterial foci with macrophages between control and pazopanib-treated larvae. We did not observe any differences in the proportion of macrophage-associated foci at timepoints between 4 and 6 dpi (Extended Data 5E). Together, these data suggest that VEGFR inhibition reduces bacterial burden specifically through restriction of vascularisation.
To determine if VEGFR inhibition also reduced infection-induced vascular permeability, we measured permeability in treated and untreated animals matched for infection burden. We found a reduction in vascular leakiness in animals treated with VEGFR inhibitor (Extended Data 5F).
Angiogenesis is thought to play an important role in tumour metastasis 5 . Analogously, in long-term monitoring experiments, we observed a decreased rate of M. marinum dissemination to distal sites in animals treated with VEGFR antagonist compared with untreated animals (OR 0.27, 95% ci 0.12 to 0.63) ( Figure 3B and Extended Data 5G). To investigate if decreased dissemination was solely a consequence of reduced bacterial growth, we examined a hypoinflammatory state caused by knockdown of an enzyme involved in eicosanoid biosynthesis, Lta4h 28 . Lta4h knockdown increased burden, limited angiogenesis and also decreased dissemination, suggesting a role for angiogenesis in dissemination independent of burden (Extended Data 5H).
We hypothesised that reduced bacterial growth due to decreased oxygen availability may contribute to overall reduced burdens. Pazopanib treatment resulted in an increased number of phd3-positive granulomas ( Figure 3C and Extended Data 5I). Moreover, pazopanib treatment increased the effectiveness of metronidazole ( Figure 3D ). These results suggest that angiogenesis is an important modulator of oxygen availability for infecting mycobacteria and that its limitation can enhance the efficacy of therapies targeting hypoxia. Metronidazole has only marginal therapeutic efficacy in human tuberculosis 29 ; our results suggest combining it or related compounds with VEGFR inhibitors that increase the hypoxic environment. Finally, we showed that targeting of VEGFR signalling could complement the first-line antitubercular drug rifampicin: combination of rifampicin and SU5416 resulted in decreased burden compared to either drug alone ( Figure 3E ).
We next addressed the therapeutic effectiveness of VEGFR inhibition in adult animals. We infected with a range of mycobacterial doses from 400-8000 CFU via intraperitoneal injection, treated with pazopanib, and observed survival. Over seventeen days, pazopanib treatment increased survival in animals infected with high doses (4000 and 8000 CFU) of M. marinum, but there was not yet appreciable mortality in the low-dose infection ( Figure 4A ). At a dose of 500 CFU, where significant mortality was not observed in the first three weeks, we observed granulomas that were completely cellular as well as ones that had developed necrotic cores by two weeks post-infection (Extended Data 6A). Many adult granulomas were hypoxic, as assessed by pimonidazole treatment and staining. Staining was largely specific to granulomas and was concentrated in the cellular rim of the necrotic area, a pattern similar to that seen in macaques 19 ( Figure 4B and Extended Data 6B).
Pazopanib treatment increased the mean distance of granulomas to the nearest vasculature (Extended Data 6C). As in larvae, treatment resulted in reduced bacterial burdens, with a mean 4-fold reduction relative to control animals over two weeks ( Figure 4C ). In week-old established infections, pazopanib treatment for one week resulted in a mean 8-fold reduction in burden (Extended Data 6D).
After six weeks of treatment, vascularisation was still significantly reduced relative to controls (Extended Data 7A). Notably, there was an increased fraction of low-burden or sterile granulomas in the pazopanib-treated animals ( Figure 4D and Extended Data 7B). In addition, the drug-treated animals displayed an increased fraction of hypoxic granulomas, and there was an association of hypoxic granulomas with low-burden lesions (Extended Data 7C and 7D). Many low-burden or sterilised hypoxic granulomas in the drug-treated animals had acellular necrotic central areas (Extended Data 6A and 7B). Studies of caseous tuberculous granulomas that are sterile in asymptomatic humans suggest that such an outcome is possible even in the normal course of TB 30 .
We conclude that angiogenesis triggered by mycobacterial granulomas is an important feature of mycobacterial pathogenesis and has significant consequences to infection pathology and progression. We have shown that interception of this angiogenic program using host-directed therapies can limit mycobacterial disease. These findings suggest the potential utility of host-targeting anti-angiogenic agents as adjunctive therapies.
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Methods

Zebrafish handling
All zebrafish husbandry and experimental procedures were performed in accordance and compliance with policies approved by the Duke University Institutional Animal Care and Use Committee (protocol A180-11-07). Clutches of eggs were collected from natural spawning and raised in filtered fish system water at 28°. Pigment development was halted in 1 dpf embryos by the addition of 1-phenyl-2-thiourea (PTU; Sigma-Aldrich; final concentration 45 μg/mL). Unless otherwise indicated, all zebrafish are from the wild-type AB strain.
Infection by microinjection
Embryos were anesthetised at 2 dpf (or 1 dpf for morphants) with tricaine (MS-222; SigmaAldrich; final concentration 160 μg/mL) and injected with approximately 200 CFU M. marinum or E. coli in an injection bolus of 10-20 nl as shown in Figure 1B . Infected embryos were then recovered back to filtered fish system water supplemented with PTU. Embryos that were physically damaged by injection handling were discarded and excluded from further analysis.
Live imaging
Conventional and time-lapse fluorescent microscopy was carried out on a Zeiss Observer Z1 inverted microscope. Embryos were anesthetised with tricaine and mounted in 3% (w/v) methylcellulose for static microscopy. Embryos for time-lapse microscopy were anesthetised with 120 μg/mL tricaine, mounted in 0.75% low melting point agarose in 96 well plates and immersed in filtered fish system water supplemented with PTU. Confocal microscopy was performed with an Olympus FV1000 confocal microscope. Images were processed with ImageJ (NIH), Photoshop CS4 (Adobe) and Volocity 5.4 image analysis software (Improvision/PerkinElmer Life and Analytical Sciences).
Image analysis
Abnormal vascular length was measured as the 2 dimensional length of vessels not seen in control embryos in Photoshop using the ruler tool. Infection burden and neutrophil units were measured as the number of pixels above background per embryo in ImageJ using binary thresholding of single channel images and the Analyze Particles function. Macrophage association was scored as having mpeg:tomato-caax expression around sites of M. marinum-wasabi expression. Dissemination was scored by comparing images of infected larvae at 4 and 6 dpi to track M. marinum infection foci.
Whole mount in situ hybridisation
Whole mount in situ hybridisation was carried out essentially as described 31 . Primers used for cloning vegfaa were previously described 32 . Primers used for cloning phd3 were: 5′ ATTCCTGTGGGCTTCTCAAC 3′ and 5′ ACACGAACCAAACTGCTCAC 3′. Images of stained embryos were collected on a Nikon AZ100 microscope.
Construction of mpeg1:tomato-caax transgene
The previously characterized mpeg1 promoter 33 was PCR amplified using the primers 5′-CCCAAACTCGAGTTGTTGGAGCACATCTGACAT-3′ and 5′-GGGAGGAAGCTTTGTTTTGCTGTCTCCTGCACT-3′. The product was subsequently cloned into p5E MCS 34 using XhoI and HindIII sites to generate p5E mpeg1.
To construct a gateway compatible Tomato-CAAX construct, the sequence of Tomato was PCR amplified with the primers 5′-GGGGACAAGTTTGTACAAAAAAGCAGGCTGGACCATGGTGAGCAAGGGCGAGG AG-3′ and 5′-GGGGACCACTTTGTACAAGAAAGCTGGGTAGATCTACTTGTAGAGCTCGTCCAT GCCG-3′. These primers introduced a silent SacI site in the 3′ end of the Tomato coding sequence and a BglII site downstream of the Tomato stop codon. The PCR product was subsequently cloned by gateway recombination (Invitrogen) into pDONR221 to generate pME Tomato.
To generate pME Tomato-CAAX, pME Tomato was digested with SacI and BglII and a linker sequence encoding the human H-Ras prenylation signal was cloned into the plasmid to generate pME Tomato-CAAX. Primer sequences for the linker were as follows: top strand-5′-CTACAAGAAGCTGAACCCTCCTGATGAGAGTGGCCCCGGCTGCATGAGCTGCAA GTGTGTGCTCTCCTA-3′ bottom strand-5′-GATCTAGGAGAGCACACACTTGCAGCTCATGCAGCCGGGGCCACTCTCATCAGG AGGGTTCAGCTTCTTGTAGAGCT-3′.
The mpeg1:tomato-caax transgene construct was subsequently constructed by recombining p5E mpeg1, pME Tomato-CAAX and p3E polyA into pDestTol2pA2, by Gateway multisite recombination (Invitrogen) as previously characterized 34 , to generate pDestTol2; mpeg1:tomato-caax.
Construction of mfap4:turquoise transgene
The mfap4 promoter was PCR amplified using the primers 5′-CATGTTCTCGAGGCGTTTCTTGGTACAGCTGG-3′ and 5′-CATGTTGGATCCCACGATctaaagtcatgaagaaaga-3′. The product was subsequently cloned into p5E MCS using XhoI and BamHI sites. The native start codon was mutated using the primer 5′-CTGAGCTGTTGAGGAGAGAGTGAGAAG[ATT]GCAGTAAGTTCTGTGGCTGTTTT ATTCC-3′ by inverse PCR with the backbone primers 5′-GTAAGTTCTGTGGCTGTTTTATTC-3′ and 5′-CTTCTCACTCTCTCCTCAACAG-3′. The final p5E mfap4 was then assembled by Gibson assembly using this single stranded oligo and the backbone.
To generate pME Turquoise2, we used the primers 5′-GGGGACAAGTTTGTACAAAAAAGCAGGCTggaccatggtgagcaagggcgaggag-3′ and 5′-GGGGACCACTTTGTACAAGAAAGCTGGGTttacttgtacagctcgtccat-3′ to amplify off pmTurquoise2 H2A (Addgene plasmid #36202 35 ). The PCR product was subsequently cloned into pDONR221 by BP cloning (Invitrogen) to generate pME Turquoise2.
The mfap4:turquoise transgene construct was subsequently constructed by recombining p5E mfap4, pME Turquoise and p3E polyA into pDestTol2pA2 to generate pDestTol2; mfap4:turquoise.
Construction of lyzC:ntr-p2A-lanYFP transgene
The previously characterised lyzC promoter was PCR amplified from the BAC CH211-250A24 (BACPAC resources, Childrens Hospital of Oakland Research Institute) using the primers 5′-CCCATAGGTACCctgatcactggtgtagtgaactc-3′ and 5′-CCCAAACTCGAGATTGTATCACTGCTGATATCTGCTTT-3′. The product was subsequently cloned into p5E MCS using KpnI and XhoI sites to generate p5E lyzC.
To generate pME Ntr, we used the primers 5′-GGGGACAAGTTTGTACAAAAAAGCAGGCTGGACCatgGCCTCCGGACTCAGATCT CGAGC-3′ and 5′-GGGGACCACTTTGTACAAGAAAGCTGGGTcCACTTCGGTTAAGGTGATGTTTTGC -3′ to amplify off pminiTol2-YFP-NTR (Gift from L. Ramakrishnan). The PCR product was subsequently cloned into pDONR221 by BP cloning (Invitrogen) to generate pME Ntr.
To generate p3E p2A-lanYFP, we used the primers 5′-GGGGACAGCTTTCTTGTACAAAGTGGttGGATCCttcagtCTCGAGatggtgagcaagggcgag gag-3′ and 5′-GGGGACAACTTTGTATAATAAAGTTGttacttgtacagctcgtccat-3′ to amplify the dimeric form of lanYFP from pNCS-dlanYFP (Allele Biotechnology). The PCR product was subsequently cloned into pDONR P2R-P3 by BP cloning (Invitrogen) to generate p3E lanYFP. p3E lanYFP was subsequently digested with BamHI and XhoI and ligated with annealed oligos encoding the p2A sequence (GATCcGGAAGCGGAGCTACTAACTTCAGCCTGCTGAAGCAGGCTGGAGACGTG GAGGAGAACCCTGGACCTc and TCGAgAGGTCCAGGGTTCTCCTCCACGTCTCCAGCCTGCTTCAGCAGGCTGAAGT TAGTAGCTCCGCTTCCg 36 ) to generate p3E p2a lanYFP.
The lyzC:ntr-p2A-lanYFP transgene construct was subsequently constructed by recombining p5E lyzC, pME Ntr and p3E p2A-lanYFP into pDestTol2pA2 to generate pDestTol2; lyzC:ntr-p2A-lanYFP.
Nucleic acid microinjection
Tol2 transposase was generated from T3TS-Tol2 37 using the mMessage mMachine T3 kit (Invitrogen). To generate transgenic zebrafish, embryos at the one-cell stage were injected with approximately 1 nL of trangenesis mixture consisting of 25 ng/μL transposase RNA and 50 ng/μL pDestTol2; transgenesis construct. Positive embryos were selected by fluorescence microscopy, raised to adulthood and transgenic founders were subsequently identified.
Spi1 morpholino sequence 5′ GATATACTGATACTCCATTGGTGGT 3′, Lta4H morpholino sequence 5′ AGCTAGGGTCTGAAACTGGAGTCAT3′. Morpholinos were injected at 10-60 μM.
Drug treatments
Metronidazole (M1547; Sigma-Aldrich; final concentration 5 mM) was dissolved in water, the relatively high concentration of metronidazole seems to be a function of bioavailability in zebrafish as higher concentrations are routinely required for nitroreductase mediated cellular ablation studies 38 . Pazopanib (sc-364564; Santa Cruz Biotechnology; final concentration 250 nM for larvae, 1 μM for adults) and SU5416 (S8442; Sigma-Aldrich; final concentration 250 nM) were dissolved in DMSO. Metronidazole, pazopanib, SU5416 were added immediately after infection and refreshed every two days for the duration of the experiment. Randomisation into drug treatment groups was achieved by random selection of infected zebrafish from a single pool prior to addition of drugs.
Microangiography
To 
Combined drug treatments
Rifampicin (R3501; Sigma-Aldrich; final concentration 50 μM) was dissolved in DMSO. To achieve a suboptimal dose of VEGFR inhibition, SU5416 was added immediately after infection at a final concentration of 200 nM and refreshed at 3 dpi. Rifampicin was added at 3 dpi and not refreshed for the duration of the experiment.
Metronidazole (final concentration 5 mM) and pazopanib (suboptimal final concentration 200 nM) were added immediately after infection and refreshed every two days for the duration of the experiment.
Adult infections
Adult zebrafish were infected with approximately 500 CFU of fluorescent M. marinum via intra peritoneal injection. Zebrafish were maintained in beakers in a dedicated incubator at 28° with a 14:10 hour light:dark cycle. Pazopanib was added to a final concentration of 1 μM immediately after infection and refreshed every two days for the duration of the experiment.
Bacterial recovery from infected adults
Infected adult zebrafish pretreated with 25 μg/ml hygromycin to reduce microbiota load for two hours prior to harvesting. Zebrafish were euthanised by tricaine overdose and homogenised by bead mill for three bursts of 15 seconds. Homogenate was plated on Middlebrook 7H10 (262710; Difco) supplemented with OADC, hygromycin (H0654; Sigma-Aldrich, 50 μg/l) and amphotericin B (SV3007801; Thermo Scientific, 10 mg/l).
Plates were grown at 30° for 10-14 days until fluorescent colonies could be counted.
Hypoxyprobe staining
Infected adult zebrafish were injected with 15 μl of a 10 mg/ml pimonidazole solution (HP7; Hypoxyprobe) every two days from 8 dpi to 14 dpi. Zebrafish were euthanised by tricaine overdose at 14 dpi, fixed in 4% PFA, decalcified in 0.5M EDTA and cyrosectioned. Frozen sections were stained with 4.3. (I) Whole mount in situ hybridisation detection of phd3 expression in uninfected (white arrow) and M. marinum infected zebrafish larvae. Blue arrows indicate phd3 expression positive larvae with purple staining, red arrow grey associated with bacteria, but lack of purple staining, indicating phd3 expression negative larva. Image is representative of data in Figure 3C . Scale bars indicate 100 μm. Error bars represent mean ± standard deviation. 
